Literature DB >> 2786472

Interleukin (IL) 4 counteracts the helper effect of IL2 on antigen-activated human B cells.

L Llorente1, M C Crevon, S Karray, T Defrance, J Banchereau, P Galanaud.   

Abstract

We tested the effect of interleukin (IL) 4 on the specific IgM antibody response induced by trinitrophenylated-polyacrylamide beads (TNP-PAA) in cultures of human B cells. T cell help was provided by exogeneous IL2. IL4 profoundly suppressed the response to optimal concentrations (50 U/ml) of IL2, with a 50% inhibitory concentration of 6 U/ml. This was due neither to a shift in the kinetics nor to a switch to an IgG response. The production of anti-TNP antibody (as measured by an enzyme-linked immunosorbent assay in the culture supernatant) was inhibited to the same extent as the generation of plaque-forming cells. The effect of IL4 was completely abolished by a neutralizing antibody toward IL4. Kinetic studies showed that IL4 had to be present during the first 48 h of culture to fully inhibit the response. The sequential stimulation of B cells by antigen and by IL2 showed that IL4 does not negatively interfere with signaling through membrane Ig but counteracts the effect of IL2 on antigen-activated B cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786472     DOI: 10.1002/eji.1830190429

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  The role of interleukin-4 in IgE and IgG subclass formation.

Authors:  H L Spiegelberg
Journal:  Springer Semin Immunopathol       Date:  1990

Review 2.  Functions of interleukin-4 on human B lymphocytes.

Authors:  J Banchereau; F Rousset
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Alterations in interleukin secretion (IL-2 and IL-4) by CD4 and CD4 CD45RO cells from common variable immunodeficiency (CVI) patients.

Authors:  J M Ferrer; J Iglesias; M Hernández; N Matamoros
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

4.  IL-4 and transforming growth factor-beta suppress human immunoglobulin secretion in vitro by surface IgD- B cells.

Authors:  C Ninomiya; H L Spiegelberg
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

5.  IL-2 infusion abrogates humoral immune responses in humans.

Authors:  D J Gottlieb; H G Prentice; H E Heslop; C Bello; M K Brenner
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

6.  Interleukin-2 may enhance or inhibit antibody production by B cells depending on intracellular cAMP concentrations.

Authors:  D Dennig; S Mecheri; J H Bourhis; M K Hoffman
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

7.  Interleukin-2 inhibits the interleukin-4-induced human IgE and IgG4 secretion in vivo.

Authors:  H L Spiegelberg; R J Falkoff; R D O'Connor; L Beck
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

8.  Dual action of IL-4 on mite antigen-induced IgE synthesis in lymphocytes from individuals with bronchial asthma.

Authors:  Y Kawano; T Noma
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

9.  Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction.

Authors:  M J Dallman; C P Larsen; P J Morris
Journal:  J Exp Med       Date:  1991-08-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.